PROTEUS, IRC Edinburgh, UK
RAPID POC DX
OPTICAL BACTERIAL IMAGING
The multidisciplinary Proteus team is developing technology to visualise bacteria and the host response in the deepest parts of human lungs in just 60 seconds, using bacteria-specific Smartprobes and fibre-based imaging. This potentially game-changing optical molecular technology will be used in critical care units, which are the largest consumer of antibiotics and an epicentre of antimicrobial resistance development in hospitals. Used at the bedside of patients who are mechanically ventilated and critically unwell, it will enable precision in diagnosing and prescribing, and has widespread applicability elsewhere in the human body for point-of-care bacterial detection and host-response monitoring.
Current Development Stage: System Integration and Testing
CARB-X Investment: Initial investment of up to $0.64m with potential option payments up to $0.48m
Initial CARB-X Investment Date: April 1, 2017
Graduation Date: April 15, 2022